A new long-acting insulin (HOE901) demonstrates less nocturnal hypoglycaemia when compared with protamine insulin in a clinical trial.

A new long-acting insulin (HOE901) demonstrates less nocturnal hypoglycaemia when compared with protamine insulin in a clinical trial.

Bibliographic Details
Main Authors:	Matthews, DR, Pfeiffer, C
Format:	Journal article
Published:	1998

Similar Items

Insulin (Technique) Induced Hypoglycaemia
by: Adlyne Reena Asirvatham, et al.
Published: (2017-05-01)

Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus.
by: Ford-Adams, M, et al.
Published: (2003)

The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
by: Rikke Mette Agesen, et al.
Published: (2019-07-01)

Switching from Neutral Protamine Hagedorn Insulin to Insulin Glargine 300 U/mL Improves Glycaemic Control and Reduces Hypoglycaemia Risk: Results of a Multicentre, Prospective, Observational Study
by: B. Wolnik, et al.
Published: (2020-01-01)

Computational Approach to Elucidating Insulin–Protamine Binding Interactions and Dynamics in Insulin NPH Formulations
by: Ketan Kumar Rohilla, et al.
Published: (2024-01-01)

Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
by: Phillips, R, et al.
Published: (1986)

Intentional hypoglycaemia in diabetic patients treated with insulin
by: Maja Ravnik-Oblak, et al.
Published: (2007-03-01)

Recurrent Postprandial Hypoglycaemia in Insulin Autoimmune Syndrome
by: Suresh Kumar Sinha, et al.
Published: (2019-08-01)

Cross-Reactivity of Insulin Immunoassays Important for Insulin Analogue Detection in Factitious Hypoglycaemia
by: Sachin K. Raj, et al.
Published: (2024-06-01)

Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease.
by: Braund, W, et al.
Published: (1987)

Insulin-receptor antibody and hypoglycaemia associated with Hodgkin's disease.
by: Khokher, M, et al.
Published: (1987)

Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report
by: Pföhler Claudia, et al.
Published: (2008-08-01)

Hypoglycaemia and monitoring practices following insulin-dextrose therapy for hyperkalaemia
by: Samuel Ford, et al.
Published: (2025-03-01)

Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit
by: Saori Deguchi, et al.
Published: (2021-03-01)

Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
by: Ilhan Satman, et al.
Published: (2013-08-01)

Acute effects of insulin and insulin‐induced hypoglycaemia on carotid body chemoreceptor activity and cardiorespiratory responses in dogs
by: Santhosh M. Baby, et al.
Published: (2023-02-01)

Recurrent hypoglycaemia in a patient with thyrotoxicosis due to Insulin autoimmune syndrome
by: S. Sureshkumar, et al.
Published: (2023-02-01)

Protamine as a barrier against the angiogenic effect of insulin: a possible role of apelin
by: Mahboobeh Yeganeh-Hajahmadi, et al.
Published: (2023-10-01)

Long‐term field study of lispro and neutral protamine Hagedorn insulins treatment in dogs with diabetes mellitus
by: Sharon Kuzi, et al.
Published: (2023-03-01)

Comparison of Insulin Lispro Protamine Suspension with NPH Insulin in Pregnant Women with Type 2 and Gestational Diabetes Mellitus: Maternal and Perinatal Outcomes
by: Antonietta Colatrella, et al.
Published: (2013-01-01)

Budget impact analysis of insulin glargine vs. isophane protamine insulin treatment for patients with type-2 diabetes and severe hypoglycemia in Thailand
by: Unchalee Permsuwan, et al.
Published: (2025-01-01)

The effect of ovine corticotrophin-releasing factor on the hormonal response to insulin-induced hypoglycaemia.
by: Howlett, T, et al.
Published: (1989)

Making surgical wards safer for patients with diabetes: reducing hypoglycaemia and insulin errors
by: Aminder Singh, et al.
Published: (2018-07-01)

Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes
by: Dario Giugliano, et al.
Published: (2012-06-01)

Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.
by: Matthew D Campbell, et al.
Published: (2014-01-01)

Efficacy of Glargine Insulin Compared with Neutral Protamine Hagedorn Insulin in Patients with Type 2 Diabetes not Controlled with Oral Hypoglycemics: A Cohort Study
by: Ebtihal Bilal, et al.
Published: (2023-08-01)

Comparing the efficacy and safety of insulin detemir versus neutral protamine hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study
by: Jing ji, et al.
Published: (2020-04-01)

Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study
by: Salah Abusnana, et al.
Published: (2019-03-01)

Cerebral blood flow increases during insulin-induced hypoglycaemia in type 1 (insulin-dependent) diabetic patients and control subjects.
by: Neil, H, et al.
Published: (1987)

Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review.
by: Mogamat-Yazied Chothia, et al.
Published: (2022-01-01)

Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review
by: Mogamat-Yazied Chothia, et al.
Published: (2022-01-01)

Insulin autoimmune syndrome – a rare cause of hypoglycaemia: a report on 2 cases
by: M. S. A. Cooray, et al.
Published: (2016-02-01)

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
by: Kristensen Peter, et al.
Published: (2012-06-01)

Insulin degludec is a new ultra-long-acting insulin analogue
by: Ivan Ivanovich Dedov, et al.
Published: (2014-07-01)

Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care
by: Guido Kramer, et al.
Published: (2021-07-01)

Hypoglycaemia among Insulin-Treated Patients with Diabetes: Southeast Asia Cohort of IO HAT Study
by: Faruque Pathan, et al.
Published: (2018-04-01)

Spontaneous Hypoglycaemia due to Insulin Autoimmune Syndrome in Six Cases, Response to Steroid Therapy and Rituximab
by: Chandar M. Batra, et al.
Published: (2024-06-01)

Self-reported hypoglycaemia in patients treated with insulin: A large Slovenian retrospectively-prospective study
by: Pongrac Barlovič Draženka, et al.
Published: (2017-10-01)

Development of a pH-Sensitive Nanoparticle via Self-Assembly of Fucoidan and Protamine for the Oral Delivery of Insulin
by: Hongying Cai, et al.
Published: (2024-10-01)

ASSESSMENT OF INSULIN AND C-PEPTIDE HALF-LIFE IN MAN BY SOMATOSTATIN SUPPRESSION AND DEMONSTRATION THAT INSULIN DELIVERY IN THE BASAL STATE IS AN ON-OFF PHENOMENON
by: Matthews, D, et al.
Published: (1983)